Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 14,500 shares at $30.00 ($435K) on 2016-09-07, disclosed to the SEC on 2016-09-09.
Open-market sale of $435k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LOXO | SELL | 2017-08-23 | $775K | — | Filing → |
| LOXO | SELL | 2017-05-24 | $649K | — | Filing → |
| LOXO | SELL | 2017-02-23 | $601K | — | Filing → |